A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| BMVC | BMVC is a potent G-quadruplex (G4) stabilizer and a selective telomerase inhibitor with an IC 50 of ~0.2 μM. BMVC inhibits Taq DNA polymerase with an IC 50 of ~2.5 μM. BMVC increases the melting temperature of G4 structure of telomere and accelerates telomere length shortening. Anticancer activities [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 627810-06-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-135775. |  |
| BMV Gag-(7-25) | It is a cell penetrating peptide. Synonyms: H-Lys-Met-Thr-Arg-Ala-Gln-Arg-Arg-Ala-Ala-Ala-Arg-Arg-Asn-Arg-Trp-Thr-Ala-Arg-OH; L-lysyl-L-methionyl-L-threonyl-L-arginyl-L-alanyl-L-glutaminyl-L-arginyl-L-arginyl-L-alanyl-L-alanyl-L-alanyl-L-arginyl-L-arginyl-L-asparagyl-L-arginyl-L-tryptophyl-L-threonyl-L-alanyl-L-arginine. Grades: ≥95%. Molecular formula: C96H170N44O24S. Mole weight: 2356.76. |  |
| BMX, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| Bmx Active human | recombinant, expressed in E. coli, ?85% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| BMX-IN-1 | BMX-IN-1 is a selective irreversible BMX inhibitor for prostate cancer. BMX-IN-1 can covalently modifies Cys496. BMX-IN-1 inhibits the proliferation of Tel-BMX-transformed Ba/F3 cells at two digit nanomolar concentrations but requires single digit micromolar concentrations to inhibit the proliferation of prostate cancer cell lines. MK2206, is able to potentiate BMX inhibitor's antiproliferation efficacy against prostate cancer cells. Uses: Designed for use in research and industrial production. Additional or Alternative Names: BMX-IN-1; BMX-IN1; BMX-IN 1. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 1431525-23-3. Molecular formula: C29H24N4O4S. Mole weight: 524.6. Purity: >98%. IUPACName: N-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide. Canonical SMILES: C=CC(NC1=CC(N2C(C=CC3=C2C4=CC(C5=CC=C(NS(=O)(C)=O)C=C5)=CC=C4N=C3)=O)=CC=C1C)=O. Product ID: ACM1431525233. Alfa Chemistry ISO 9001:2015 Certified. |  |
| BMX-IN-1 | BMX-IN-1 selectively and irreversibly inhibits BMX (IC50=8nM) that is significant for ischemia-mediated arteriogenesis and lymphangiogenesis regulation. It also inhibits the proliferation of RV-1 (GI50s=2.54μM), DU-145 (GI50s=4.38μM), PC-3 (GI50s=5.37nM). Synonyms: N-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamideBMX-IN-1; BMX-IN1; BMX-IN 1.1431525-23-3GTPL9269SCHEMBL17052523BDBM102620CS-1295; HY-80002; W-6056; CS 1295; HY 80002; W 6056; CS1295; HY80002; W6056Example 1-14 [ WO2014063054]N-[5-[9-[4-(methanesulfonamido)phenyl]. CAS No. 1431525-23-3. Molecular formula: C29H24N4O4S. Mole weight: 524.59. | |
| BMX-IN-1 | A cell-permeable tricyclic quinoline-acrylamide compound that potently inhibits BMX and BTK kinase activity (IC50 = 8 and 10.4nM, respectively) by covalently targeting ATP-binding site cysteine, while being less potent against TEC family kinases TEC, JAK3, BLK with the same conserved cysteine (IC50 = 175, 377, and 653nM, respectively). Only PI 3-K gamma/PIK3CG, SBK1, PIP5K2C (by ≥94% at 1uM), and TXK (by 75% at 1uM) are significantly inhibited by BMX-IN-1 in a selectivity profiling against 437 other kinase constructs. Potently inhibits the proliferation of TEL-BMX transformed Ba/F3 Ba/F3 (GI50 = 25nM), while being much less effective against TEL-BLK, TEL-JAK1, TEL-JAK2, TEL-JAK3, or TEL-TYK2E957D transformed Ba/F3 (GI50 = ≥3.64uM) or a panel of 5 prostate cancer cell lines (GI50 ≥2.46uM). Group: Biochemicals. Alternative Names: N- (2-Methyl-5- (9- (4- (methylsulfonamido) phenyl) -2-oxobenzo[h][1, 6]naphthyridin-1 (2H) -yl) phenyl) acrylamide, BMX/BTK Inhibitor, Bruton's Tyrosine Kinase Inhibitor IV, BLK Inhibitor I, BMX Inhibitor I, JAK3 Inhibitor XIII, PI 3-K Inhibitor XX, PIP5K2C Inhibitor I, SBK1 Inhibitor I, TEC Inhibitor I, TXK Inhibitor I. Grades: Highly Purified. CAS No. 1431525-23-4. Pack Sizes: 10mg. Molecular Formula: C??H??N?O?S. US Biological Life Sciences. |  Worldwide |
| BMY 14802 | BMY 14802 is a sigma-1 receptor ( σ1R ) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinson's disease (PD) model, with down-regulating the expression of AIM [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 105565-56-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-153091. | |
| BMY-14802 | ?97% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BMY 14802 hydrochloride | BMY 14802 hydrochloride is a potent sigma receptor antagonist (IC50 = 112 nM) with weak affinity for 5-HT1A and α1 receptors. BMY 14802 is potentially used as an atypical antipsychotic agent for schizophrenia treatment. Uses: Potential atypical antipsychotic agent. Synonyms: BMY 14802 hydrochloride; BMS-181100 hydrochloride; BMY14802 hydrochloride; BMS181100 hydrochloride; BMY-14802 hydrochloride; BMS 181100 hydrochloride; BMY 14802 HCl; α-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol hydrochloride. Grades: ≥98% by HPLC. CAS No. 105565-55-7. Molecular formula: C18H22F2N4O.HCl. Mole weight: 384.86. | |
| BMY-14802 hydrochloride | BMY-14802 hydrochloride (BMY-14802-1) is a selective and orally active sigma receptor antagonist with an IC 50 of 112 nM. BMY-14802 hydrochloride is also a 5-HT1A and adrenergic α1 receptors agonist. BMY-14802 hydrochloride has antipsychotic effects [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMY-14802-1; BMS 181100 hydrochloride. CAS No. 105565-55-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108509. | |
| BMY-28160 | BMY-28160 is an ester peptide antibiotic produced by Bacillus circulans H913-B4. It has anti-gram-positive bacteria, negative bacteria, anaerobic bacteria and fungi activity. Synonyms: Polypeptin A, 2-L-valine-9-L-serine-. CAS No. 94593-78-9. Molecular formula: C53H90N12O12. Mole weight: 1087.35. | |
| BMY-28190 | BMY-28190 is an antiviral antibiotic produced by Streptoalloteichus hindustanus E46594, which is a complex composed of D-a.Z-diaminobutyric acid. It has weak anti-gram-positive and negative bacteria activity, but has a strong inhibitory effect on type 1 herpes simplex virus (HSV-1), with IC50 of 2.8 μg/mL. CAS No. 117153-91-0. Molecular formula: (C4H8N2O)n. | |
| Bmy 42393 | BMY-42393 is a selective platelet aggregation inhibitor. It is also a prostacyclin partial agonist that inhibited ADP, collagen and thrombin-induced platelet aggregation with IC50 value range from 0.3 to 2.0 mM. BMY-42393 can stimulate platelet adenylate cyclase with EC50 value of 25 nM. BMY 42393 can also inhibit thrombin-induced elevation of intracellular free calcium. Research for the treatment of Hyperlipidaemia was discontinued. Uses: Hyperlipidaemia. Synonyms: BMY-42393; BMY 42393; BMY42393. SCHEMBL675089; AC1L304B; CHEMBL117835;2-[3-[2-(4,5-diphenyl-1,3-oxazol-2-yl)ethyl]phenoxy]acetic acid. Grades: 98%. CAS No. 136451-58-6. Molecular formula: C25H21NO4. Mole weight: 399.45. | |
| BMY 45778 | BMY 45778 is a non-prostanoid prostacyclin mimetic that acts as a partial agonist of IP1 prostacyclin receptors. It inhibits platelet aggregation in vitro (IC50 = 27-35 nM). Synonyms: BMY 45778; BMY45778; BMY-45778. [3-(4,5-Diphenyl[2,4'-bioxazol]-5'-yl)phenoxy]acetic acid. Grades: ≥99% by HPLC. CAS No. 152575-66-1. Molecular formula: C26H18N2O5. Mole weight: 438.44. | |
| BMY 45778 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BMY 7378 | BMY 7378 is a multi-targeted inhibitor of α2C-adrenoceptor and α1D-adrenoceptor with pKi of 6.54 and 8.2, respectively, and acts as a mixed agonist and antagonist for 5-HT1A receptor with pKi of 8.3. Uses: Adrenergic alpha-antagonists. Synonyms: BMY7378; BMY-7378; 1,1-Cyclopentanediacetimide, N-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-, dihydrochloride; N-(2-(4-(o-Methoxyphenyl)-1-piperazinyl)ethyl)-1,1-cyclopentanediacetimide dihydrochloride. Grades: >98%. CAS No. 21102-95-4. Molecular formula: C22H33Cl2N3O3. Mole weight: 458.42. | |
| BMY 7378 | BMY 7378 is a selective antagonist of α 1D -adrenoceptor (α 1D -AR). BMY 7378 binds to membranes expressing the cloned rat α 1D -AR with a >100-fold higher affinity ( K i =2 nM) than binding to either the cloned rat α 1A -AR (K i =800 nM) or the hamster α 1B -AR ( K i =600 nM). BMY 7378 is a 5-HT 1A receptor partial agonist [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 21102-95-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-100554. | |
| BMY 7378 dihydrochloride | BMY 7378 dihydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 21102-95-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| BMY 7378 dihydrochloride | ?98% (HPLC), solid. Group: Fluorescence/luminescence spectroscopy. | |
| BN-104 | BN-104 (BNM-1192) is an effective selective brain membrane protein inhibitor with oral activity, and it's also a Menin inhibitor, it can block the Menin-MLL interaction and leads to the degradation of Menin protein. BN-104 is a weak hERG inhibitor, with an IC 50 greater than 100 μM. BN-104 has anti-tumor activity and can be used in cancer research, such as for acute myeloid leukemia [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BNM-1192; Menin-MLL inhibitor 27. CAS No. 2938995-50-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-153714. | |
| BN-227F | BN-227F is an antibiotic produced by Pseudomonas sp. BN-227. It has anti-gram-positive and negative bacteria activity. Synonyms: Antibiotic BN 227F. CAS No. 72907-24-5. Molecular formula: C21H24FeN3O9. Mole weight: 518.27. | |
| BN82002 hydrochloride | BN82002 hydrochloride is a potent, selective and irreversible inhibitor of CDC25 phosphatase family. BN82002 hydrochloride inhibits CDC25A, CDC25B2, CDC25B3, CDC25C CDC25A, and 25C-cat with IC 50 values of 2.4, 3.9, 6.3, 5.4, and 4.6 μM, respectively. BN82002 hydrochloride displays ~20-fold greater selectivity over CD45 tyrosine phosphatase [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1049740-43-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-112776A. | |
| Bn-AFP1 | Bn-AFP1 was found in Brassica napus. It has effects on fungi. | |
| b-Naphthoflavone 99+% | b-Naphthoflavone 99+%. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 1g, 5g, 25g. US Biological Life Sciences. | Worldwide |
| b-Naphthoxyacetic acid 98+% | b-Naphthoxyacetic acid 98+%. Group: Biochemicals. Grades: Reagent Grade. CAS No. 120-23-0. Pack Sizes: 100g, 1Kg, 5Kg, 10Kg. US Biological Life Sciences. | Worldwide |
| b-Naphthyl-b-maltotrioside | b-Naphthyl-b-maltotrioside is a highly esteemed enzymatic substrate extensively employed in the realm of biomedical science, encompassing a consequential instrument empowering the analysis of lactase insufficiency and enzyme efficacy. Molecular formula: C28H38O16. Mole weight: 630.59. | |
| BNAs in Soil | certified reference material. Group: Certified reference materials (crms). | |
| BNAs in Soil - PT | Proficiency Testing Material. Group: Atomic absorption spectroscopy (aas). | |
| BNAs - Loam 1 | certified reference material, pkg of 100 g. Group: Certified reference materials (crms). | |
| BNAs - Loamy Sand 1 | certified reference material, pkg of 100 g. Group: Certified reference materials (crms). | |
| BNAs - Sandy Loam 1 | pkg of 50 g. Group: Certified reference materials (crms). | |
| BNAs - Sandy Soil 1 | pkg of 100 g. Group: Certified reference materials (crms). | |
| BNC-105 | BNC105 is a novel compound being developed by Bionomics as a Vascular Disrupting Agent (VDA) for treatment of cancer. VDAs are drugs that disrupt the blood vessels that nourish tumours. BNC105 acts as a tubulin polymerization inhibitor and displays 80-fold higher potency against endothelial cells than that of CA4P. CA4P is a VDA currently under evaluation in phase III clinical trials. BNC105 is more potent and offers a wider therapeutic window. CA4P produces 90% vascular disruption at its no observed adverse event level (NOAEL), whereas BNC105 causes 95% vascular disruption at 1/8th of its NOAEL. Tissue distribution analysis of BNC105 in tumor-bearing mice showed that while the drug is cleared from all tissues 24 hours after administration, it is still present at high concentrations within the solid tumor mass. Furthermore, BNC105 treatment causes tumor regressions with complete tumor clearance in 20% of treated animals. Uses: Designed for use in research and industrial production. Additional or Alternative Names: BCN105; BCN-105; BCN 105. Product Category: Inhibitors. Appearance: Beige fluffy powder. CAS No. 945771-74-4. Molecular formula: C20H20O7. Mole weight: 372.37. Purity: >98%. IUPACName: (7-hydroxy-6-methoxy-2-methylbenzofuran-3-yl)(3,4,5-trimethoxyphenyl)methanone. Canonical SMILES: O=C(C1=C(C)OC2=C(O)C(OC)=CC=C12)C3=CC(OC)=C(OC)C(OC)=C3. Product ID: ACM945771744. Alfa Chemistry ISO 9001:2015 Certified. Categories: BC | |
| BNC-105 | BNC105 is a novel compound being developed by Bionomics as a Vascular Disrupting Agent (VDA) for treatment of cancer. VDAs are drugs that disrupt the blood vessels that nourish tumours. BNC105 acts as a tubulin polymerization inhibitor and displays 80-fold higher potency against endothelial cells than that of CA4P. CA4P is a VDA currently under evaluation in phase III clinical trials. BNC105 is more potent and offers a wider therapeutic window. CA4P produces 90% vascular disruption at its no observed adverse event level (NOAEL), whereas BNC105 causes 95% vascular disruption at 1/8th of its NOAEL. Tissue distribution analysis of BNC105 in tumor-bearing mice showed that while the drug is cleared from all tissues 24 hours after administration, it is still present at high concentrations within the solid tumor mass. Furthermore, BNC105 treatment causes tumor regressions with complete tumor clearance in 20% of treated animals. Synonyms: BCN-105; BCN105; BCN 105. CAS No. 945771-74-4. Molecular formula: C20H20O7. Mole weight: 372.373. | |
| BNC105P | BNC105P is a benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities. Upon administration vascular disrupting agent BNC105P, the disodium phosphate ester of BNC105, is rapidly converted to BNC105; in activated endothelial cells, BNC105 binds to tubulin and inhibits its polymerization, which may result in a blockage of mitotic spindle formation, cell cycle arrest, and disruption of the tumor vasculature. Hypoxic conditions ensue, depriving tumor cells of nutrients and resulting in tumor cell apoptosis. In addition to its VDA activity, this agent has a direct cytotoxic effect on tumor cells by inhibiting tubulin polymerization. BNC105 is not a substrate for the multidrug-resistance P-glycoprotein (Pgp) transporter. Check for active clinical trials or closed clinical trials using this agent. Synonyms: BNC105P; BNC 105P; BNC-105P. CAS No. 945771-96-0. Molecular formula: C20H19Na2O10P. Mole weight: 496.32. | |
| b-Nicotinamide adenine dinucleotide 3'-phosphate sodium salt hydrate | b-Nicotinamide adenine dinucleotide 3'-phosphate sodium salt hydrate, a pivotal coenzyme in the biomedical arena, exhibits its significance as a redox carrier and electron donor in diverse metabolic reactions. With its application in the amelioration of oxidative stress-induced ailments, including cardiovascular diseases and neurological disorders, this product assumes a critical function in cellular energy synthesis and the preservation of cellular well-being. Imbibed with indispensability, it perpetuates the vitality of the biotic system. Molecular formula: C21H27N7O17P3·xNa·yH20. Mole weight: 742.40 (anhydrous free acid). | |
| b-Nicotinamide adenine dinucleotide phosphate disodium salt | b-Nicotinamide adenine dinucleotide phosphate disodium salt, an indispensable coenzyme, demonstrates pivotal significance in diverse biochemical reactions. This coveted compound finds extensive employment within the biomedical domain, catering to research and therapeutic exigencies. Its multifarious application encompasses the meticulous scrutiny of cellular metabolism, DNA repair mechanisms and intricate redox reactions. Moreover, it assumes a vital role in alleviating maladies associated with oxidative stress, namely neurodegenerative disorders and cardiovascular ailments. Molecular formula: C21H26N7O19P3·2Na. Mole weight: 819.37. | |
| b-Nicotinamide adenine dinucleotide phosphate disodium salt | b-Nicotinamide adenine dinucleotide phosphate disodium salt. Group: Biochemicals. Alternative Names: b-NADH phosphate disodium salt. Grades: Highly Purified. CAS No. 24292-60-2. Pack Sizes: 1g, 2g, 5g, 10g, 25g. Molecular Formula: C21H26N7Na2O17P3. US Biological Life Sciences. | Worldwide |
| b-Nicotinamide adenine dinucleotide phosphate hydrate | b-Nicotinamide adenine dinucleotide phosphate hydrate. Group: Biochemicals. Alternative Names: b-NADP. Grades: Highly Purified. CAS No. 53-59-8. Pack Sizes: 10g, 25g, 50g, 100g, 250g. Molecular Formula: C21H28N7O17P3·xH2O. US Biological Life Sciences. | Worldwide |
| b-Nicotinamide adenine dinucleotide phosphate hydrate | Coenzyme and regenerating electron donor in catabolic processes. Synonyms: b-NADP; Coenzyme II. Molecular formula: C21H28N7O17P3·xH2O. Mole weight: 743.41 (anydrous basis). | |
| b-Nicotinamide adenine dinucleotide phosphate potassium salt hydrate | b-Nicotinamide adenine dinucleotide phosphate potassium salt hydrate. Group: Biochemicals. Alternative Names: coenzyme II; b-NADP-K; Triphosphopyridine nucleotide potassium salt; TPN. Grades: Highly Purified. CAS No. 68141-45-7. Pack Sizes: 100mg, 250mg, 500mg, 1g, 2g. Molecular Formula: C21H27KN7O17P3. US Biological Life Sciences. | Worldwide |
| b-Nicotinamide adenine dinucleotide phosphate potassium salt hydrate | b-Nicotinamide adenine dinucleotide phosphate potassium salt hydrate exemplifies an essential coenzyme that assumes a pivotal function in diverse biochemical reactions. This compound emerges as uniquely advantageous towards interrogating cellular metabolism, enzyme kinetics and redox reactions. Synonyms: coenzyme II; b-NADP-K; Triphosphopyridine nucleotide potassium salt; TPN; [5-(6-aminopurin-9-yl)-3-hydroxy-4-(oxyphosphinyloxyphosphinyl)oxolan-2-yl]met hyl{[5- (3-carbamoylpyridyl)-3, 4-dihydroxyoxolan-2-yl]methoxy} (hydroxyphosphoryl)hydrogen phosphate,potassium salt; Beta-nadp potassium salt; Nadp monopotassium salt. Grades: ≥ 90%. CAS No. 68141-45-7. Molecular formula: C21H27KN7O17P3. Mole weight: 781.50. | |
| b-Nicotinamide adenine dinucleotide phosphate, reduced form, disodium salt | b-Nicotinamide adenine dinucleotide phosphate, reduced form, disodium salt. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 250mg, 500mg, 1g, 2g, 5g. US Biological Life Sciences. | Worldwide |
| b-Nicotinamide Adenine Dinucleotide Phosphate, reduced form, tetrasodium salt ( β-NADPH) | One of the biologically active forms of nicotinic acid. Differs from NAD by an additional phosphate group at the 2-position of the adenosine moiety. Serves as a coenzyme of hydrogenases and dehydrogenases. Present in living cells primarily in the reduced form (NADPH) and is involved in synthetic reactions. Group: Biochemicals. Alternative Names: 2'-(Dihydrogen Phosphate) 5'-(Trihydrogen Pyrophosphate) adenosine 5'5'-Ester 1,4-Dihydro-1- β -D-ribofuranosyl nicotinamide Tetrasodium Salt Hydrate; β-NADPH; 2?-NADPH Hydrate; Coenzyme II Reduced Tetrasodium Salt Hydrate; Triphosphopyridine Nucleotide Reduced Tetrasodium Salt Hydrate; Dihydronicotinamide Adenine Dinucleotide Phosphate Tetrasodium Salt Hydrate. Grades: Highly Purified. CAS No. 2646-71-1. Pack Sizes: 100mg, 250mg, 500mg, 1g. Molecular Formula: C??H??N?Na?O??P?; xH?O, Molecular Weight: 833.35. US Biological Life Sciences. | Worldwide |
| b-Nicotinamide riboside chloride | b-Nicotinamide riboside chloride is an essential biomedical innovation, emerging as a distinguished precursor of the esteemed coenzyme, nicotinamide adenine dinucleotide (NAD+). At the helm of cellular energy metabolism, NAD+ assuming an indispensable role and remains entwined in the intricate web of age-related ailments. Synonyms: 3-(Aminocarbonyl)-1-a-D-ribofuranosyl-pyridinium chloride; Nicotinamide riboside (chloride); 3-Carbamoyl-1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium chloride; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide chloride. Grades: ≥ 98%. CAS No. 23111-00-4. Molecular formula: C11H15N2O5·Cl. Mole weight: 290.70. | |
| b-Nicotyrine (3-(1-Methylpyrrol-2-yl)pyridine) | Nicotryrine is an alkaloid derived from the dehydrogenation of nicotine and its analog, nornicotine. Group: Biochemicals. Alternative Names: 3-(1-Methylpyrrol-2-yl)pyridine. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| b-Nitrostyrene | b-Nitrostyrene. Group: Biochemicals. Alternative Names: (2-Nitrovinyl)benzene. Grades: Highly Purified. CAS No. 102-96-5. Pack Sizes: 250g, 500g, 1kg. Molecular Formula: C8H7NO2. US Biological Life Sciences. | Worldwide |
| Bnlm | Bnlm is a Grp94 selective inhibitors. Grades: >98%. CAS No. 1380296-82-1. Molecular formula: C20H19ClN2O2. Mole weight: 386.83. | |
| BNN6 | BNN6 is a thermoresponsive nitric oxide (NO) donor that often works by binding to a carrier. BNN6 decomposes under the heat stimulation generated by photothermal action, releasing high concentrations of NO, which exerts anti-tumor activity by inducing tumor cell apoptosis and inhibiting their repair. BNN6 can be used to synthesize the multifunctional biosensor BNN6-BiTiS3-iRGD, which exerts a synergistic anti-cancer effect with photothermal therapy (PTT)[1][2][3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 106476-75-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-164117. | |
| BNO1 | BNO1. Uses: Designed for use in research and industrial production. Product Category: Organic Light Emitting Diode (OLED). CAS No. 2897674-07-4. Molecular formula: C66H70B2N2O2. Mole weight: 944.9 g/mol. Product ID: ACM2897674074. Alfa Chemistry ISO 9001:2015 Certified. Categories: Bnois King. | |
| b-Nornicotyrine (2-(3-Pyridyl)pyrrole) | b-Nornicotyrine (2-(3-Pyridyl)pyrrole). Group: Biochemicals. Alternative Names: 2-(3-Pyridyl)pyrrole. Grades: Highly Purified. CAS No. 494-98-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| BNP3FL | BNP3FL. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N,N'-Bis(naphthalen-2-yl)-N,N'-bis(phenyl)-tris-(9,9-dimethylfluorenylene). Product Category: Organic Light Emitting Diode (OLED). CAS No. 669016-17-5. Molecular formula: C77H60N2. Mole weight: 1013.31 g/mol. Product ID: ACM669016175. Alfa Chemistry ISO 9001:2015 Certified. | |
| BNP-45 (mouse) | BNP-45 (mouse), a circulating form of mouse brain natriuretic peptide isolated from mouse heart, has potent hypotensive and natriuretic potency. Synonyms: Brain Natriuretic Peptide-45 (mouse); H-Ser-Gln-Gly-Ser-Thr-Leu-Arg-Val-Gln-Gln-Arg-Pro-Gln-Asn-Ser-Lys-Val-Thr-His-Ile-Ser-Ser-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Gly-Ser-Val-Ser-Arg-Leu-Gly-Cys-Asn-Ala-Leu-Lys-Leu-Leu-OH (Disulfide bridge: Cys23-Cys39). Grades: ≥95%. CAS No. 1816939-52-2. Molecular formula: C209H354N70O63S2. Mole weight: 4919.61. | |
| BNP-45 rat | BNP-45 rat is a circulating hormone with diuretic and hypotensive effects. It is also a 45-amino acid brain natriuretic peptide isolated from the rat heart. Synonyms: Brain natriuretic peptide-45 rat; H-Ser-Gln-Asp-Ser-Ala-Phe-Arg-Ile-Gln-Glu-Arg-Leu-Arg-Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe-OH; L-Phenylalanine, L-seryl-L-glutaminyl-L-a-aspartyl-L-seryl-L-alanyl-L-phenylalanyl-L-arginyl-L-isoleucyl-L-glutaminyl-L-a-glutamyl-L-arginyl-L-leucyl-L-arginyl-L-asparaginyl-L-seryl-L-lysyl-L-methionyl-L-alanyl-L-histidyl-L-seryl-L-seryl-L-seryl-L-cysteiny-; BNP-45 (51-95), Rat. Grades: ≥95%. CAS No. 123337-89-3. Molecular formula: C213H349N71O65S3. Mole weight: 5040.67. | |
| B-NPB | B-NPB. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N,N'-Bis(naphthalen-2-yl)-N,N'-bis(phenyl)-benzidine. Product Category: Organic Light Emitting Diode (OLED). CAS No. 139255-17-7. Molecular formula: C44H32N2. Mole weight: 588.74 g/mol. Product ID: ACM139255177. Alfa Chemistry ISO 9001:2015 Certified. Categories: BNPB. | |
| BNP, Positive Control (Natriuretic Peptides B, Gamma-brain Natriuretic Peptide, NPPB) | BNP, Positive Control (Natriuretic Peptides B, Gamma-brain Natriuretic Peptide, NPPB). Group: Molecular Biology. Pack Sizes: 15ul. US Biological Life Sciences. | Worldwide |
| BNS | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BNS | BNS is a cell penetrant, potent and selective PHD2 (prolyl-hydroxylase 2) inhibitor [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1417440-37-9. Pack Sizes: 5 mg. Product ID: HY-119351. | |
| BNS-22 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BNT411 | BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro. BNT411 has anticancer activity and can be used in cancer research, including non-small cell lung cancer, pancreatic cancer, and untreated extensive-stage small cell lung cancer (ES-SCLC) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2296821-50-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-160715. | |
| BNTX maleate | BNTX maleate is a selective DOR (δ1 opioid receptor) antagonist with Ki of 0.83 nM (rat). It inhibits neurogenic ion transport in porcine ileal mucosa. Synonyms: 7-Benzylidenenaltrexone maleate. Grades: ≥99%. CAS No. 864461-31-4. Molecular formula: C27H27NO4·C4H4O4. Mole weight: 545.59. | |
| BNTX maleate | BNTX maleate. Group: Biochemicals. Grades: Purified. CAS No. 864461-31-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| BNTX maleate salt hydrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BO-264 | BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (TACC3) inhibitor with an IC50 of 188 nM and a Kd of 1.5 nM. BO-264 specifically blocks the function of FGFR3-TACC3 fusion protein. BO-264 induces spindle assembly checkpoint (SAC)-dependent mitotic arrest, DNA damage and apoptosis. BO-264 has broad-spectrum antitumor activity[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2408648-20-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-135960. | |
| BO-264 | BO-264 is a highly effective and orally active transforming acidic coiled coil 3 (TACC3) inhibitor with IC50 of 188 nM and Kd of 1.5 nM. It has broad-spectrum anti-tumor activity. Synonyms: BO264; BCP33848; EX-A3407; S8965. Grades: 98%. CAS No. 2408648-20-2. Molecular formula: C18H19N5O3. Mole weight: 353.4. | |
| BO-264 | BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (TACC3) inhibitor with an IC50 of 188 nM and a Kd of 1.5 nM. BO-264 demonstrated superior anti-proliferative activity to the two currently reported TACC3 inhibitors, especially in aggressive breast cancer subtypes, basal and HER2+, via spindle assembly checkpoint (SAC)-dependent mitotic arrest, DNA damage and apoptosis, while the cytotoxicity against normal breast cells was negligible. Uses: Designed for use in research and industrial production. Additional or Alternative Names: BO-264; BO 264; BO264. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 2408648-20-2. Molecular formula: C18H19N5O3. Mole weight: 353.38. Purity: >98%. IUPACName: 3-(4-methoxyphenyl)-N-(2-morpholinopyrimidin-4-yl)isoxazol-5-amine. Canonical SMILES: COC1=CC=C(C2=NOC(NC3=NC(N4CCOCC4)=NC=C3)=C2)C=C1. Product ID: ACM2408648202. Alfa Chemistry ISO 9001:2015 Certified. Categories: BF 2649. | |
| BO3482 | BO3482, a dithiocarbamate carbapenem, inhibits the growth of methicillin-resistant Staphylococci (MRS) (MIC90= 6.25 mg/mL) and has a dithiocarbamate chain at the C-2 position of 1beta-methyl-carbapenem. Synonyms: BO3482; BO 3482; BO-3482; (4R, 5S, 6S)-6-[ (1R)-1-hydroxyethyl]-3-[2-hydroxyethyl (methyl)carbamothioyl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3. 2. 0]hept-2-ene-2-carboxylic acid;sodium. CAS No. 198013-53-5. Molecular formula: C14H20N2NaO5S2. Mole weight: 383.44. | |
| Boanmycin Hydrochloride Liposome | Boanmycin hydrochloride has the same chemical structure as bleomycin A6 and has broad-spectrum anticancer effects. This product is a pre-formulated liposome with boanmycin hydrochloride. It is only for research purposes. Group: Drug-loaded liposome. Categories: liposomes, niosomes, ethosomes, and transfersomes. |  |
| Bobcat339 | Bobcat339 is a potent and selective cytosine-based inhibitor of TET enzyme , with IC 50 s of 33 μM and 73 μM for TET1 and TET2 , respectively. Bobcat339 is useful to the field of epigenetics and serves as a starting point for new therapeutics that target DNA methylation and gene transcription [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2280037-51-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-111558. | |
Our database is helping our users find suppliers everyday.
